# Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

> **NCT00302640** · PHASE2,PHASE3 · COMPLETED · sponsor: **Romark Laboratories L.C.** · enrollment: 50 (actual)

## Conditions studied

- Rotavirus Infection
- Adenoviridae Infection
- Norovirus Infection

## Interventions

- **DRUG:** Alinia (nitazoxanide)

## Key facts

- **NCT ID:** NCT00302640
- **Lead sponsor:** Romark Laboratories L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2012-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00302640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00302640, "Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00302640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*